Insider Buying in Sarepta Therapeutics, Inc. (SRPT)

On September 9, 2019, Michael Bonney – Director of Sarepta Therapeutics, Inc. (SRPT)– purchased 2,000 shares of SRPT at $86.74. His out of pocket cost was $173,480.